Patients n | 206 |
Age years | 59±15 |
Female % | 65 |
BMI kg·m−2 | 25±5 |
Smoking status % | |
Current | 1 |
Ex | 23 |
Never | 76 |
Bronchiectasis aetiology % | |
Idiopathic | 41 |
Post-infective | 27 |
Immunodeficiency | 11 |
ABPA | 8 |
Other# | 13 |
Spirometry | |
FEV1 % pred (range) | 75±28 (18.1–150.7) |
FVC % pred | 91±25 |
FEV1/FVC | 66±14 |
Sputum colonisation with microorganisms¶ % | |
Pseudomonas aeruginosa | 26 |
Other | 24 |
None | 61 |
Exacerbations in past 12 months % | |
0 | 13 |
1 | 12 |
2 | 15 |
3 | 17 |
4 | 11 |
5 | 10 |
>5 | 22 |
Hospitalisations in last 12 months % | |
0 | 79 |
1 | 11 |
2 | 4 |
3 | 1 |
4 | 2 |
5 | 1 |
>5 | 2 |
Comorbidities+ % | |
Asthma | 25 |
Rhinosinusitis | 23 |
Cardiovascular | 14 |
COPD | 9 |
Lung surgery | 6 |
Diabetes mellitus | 4 |
Lung fibrosis/sarcoidosis | 3 |
Malignancy | 1 |
Respiratory symptoms | |
VAS Dyspnoea | 27 (10–53) |
VAS Cough | 28 (12–53) |
VAS Sputum | 30 (11–56) |
SGRQ | |
SGRQ Total | 43±20 |
SGRQ Activities | 50±27 |
SGRQ Symptoms | 63±21 |
SGRQ Impact | 33±20 |